Results 211 to 220 of about 220,141 (335)
CLPB deficiency-associated congenital neutropenia: A rare case report and literature review. [PDF]
Sun Y, Tang M, He J, Hu X, Li M, Tan L.
europepmc +1 more source
Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra [PDF]
A.L. Manson +12 more
core +1 more source
This study was the largest sample size of first‐line third‐generation TKIs combined chemotherapy among advanced EGFRm NSCLC patients in the real world. It was never reported that aumolertinib and furmonertinib showed comparable PFS benefits to osimertinib in combination with chemotherapy. The overall safety profile remained acceptable. ABSTRACT FLAURA2
YuQin Jiang +9 more
wiley +1 more source
A Case of Parvovirus B19 Infection Mimicking Mumps Virus Infection in a Healthy Adult. [PDF]
Sedogawa H +5 more
europepmc +1 more source
Combinatorial targeting of MYC/BCL2‐associated vulnerabilities in high‐grade B‐cell lymphoma
British Journal of Haematology, EarlyView.
Giulio Donati +6 more
wiley +1 more source
The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota +12 more
wiley +1 more source
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group). [PDF]
Antherieu G +6 more
europepmc +1 more source
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka +17 more
wiley +1 more source

